Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy

Z Xu, X Han, D Ou, T Liu, Z Li, G Jiang, J Liu… - Applied microbiology …, 2020 - Springer
Autophagy is a highly conserved catabolic process and participates in a variety of cellular
biological activities. The phosphoinositide 3-kinase (PI3K)/protein kinase B …

Combination of an autophagy inducer and an autophagy inhibitor: a smarter strategy emerging in cancer therapy

T Liu, J Zhang, K Li, L Deng, H Wang - Frontiers in pharmacology, 2020 - frontiersin.org
Autophagy is considered a cytoprotective function in cancer therapy under certain conditions
and is a drug resistance mechanism that represents a clinical obstacle to successful cancer …

[HTML][HTML] Non-apoptotic cell death in ovarian cancer: Treatment, resistance and prognosis

J Chen, Z Wei, K Fu, Y Duan, M Zhang, K Li… - Biomedicine & …, 2022 - Elsevier
Ovarian cancer is mostly diagnosed at an advanced stage due to the absence of effective
screening methods and specific symptoms. Repeated chemotherapy resistance and …

[HTML][HTML] Blockage of autophagy for cancer therapy: a comprehensive review

AMIA Hassan, Y Zhao, X Chen, C He - International Journal of Molecular …, 2024 - mdpi.com
The incidence and mortality of cancer are increasing, making it a leading cause of death
worldwide. Conventional treatments such as surgery, radiotherapy, and chemotherapy face …

Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer

BM Gąsiorkiewicz, P Koczurkiewicz-Adamczyk… - Investigational new …, 2021 - Springer
Although cisplatin is one of the most common antineoplastic drug, its successful utilisation in
cancer treatment is limited by the drug resistance. Multiple attempts have been made to find …

Protective effects of notoginsenoside R1 via regulation of the PI3K-Akt-mTOR/JNK pathway in neonatal cerebral hypoxic–ischemic brain injury

L Tu, Y Wang, D Chen, P Xiang, J Shen, Y Li… - Neurochemical …, 2018 - Springer
Abstract Notoginsenoside R1 (NGR1) is a predominant phytoestrogen extracted from Panax
notoginseng that has recently been reported to play important roles in the treatment of …

Autophagy takes center stage as a possible cancer hallmark

JG Alvarez-Meythaler, Y Garcia-Mayea, C Mir… - Frontiers in …, 2020 - frontiersin.org
Cancer remains one of the leading causes of death worldwide, despite significant advances
in cancer research and improvements in anticancer therapies. One of the major obstacles to …

MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer

M Ashrafizadeh, A Zarrabi, K Hushmandi, F Hashemi… - Life sciences, 2020 - Elsevier
The resistance of cancer cells into chemotherapy has restricted the efficiency of anti-tumor
drugs. Oxaliplatin (OX) being an anti-tumor agent/drug is extensively used in the treatment of …

4‑Acetylantroquinonol B enhances cell death and inhibits autophagy by downregulating the PI3K/Akt/MDR1 pathway in gemcitabine‑resistant pancreatic cancer cells

YY Chen, SY Chen, TJ Li, TW Lin… - Oncology …, 2022 - spandidos-publications.com
Gemcitabine (GEM) is a typical chemotherapeutic drug used to treat pancreatic cancer, but
GEM resistance develops within weeks after chemotherapy. Hence, the development of a …

[HTML][HTML] Thymoquinone suppresses the proliferation, migration and invasiveness through regulating ROS, autophagic flux and miR-877-5p in human bladder …

X Zhou, F Wang, H Wu, X Chen, Y Zhang… - … Journal of Biological …, 2021 - ncbi.nlm.nih.gov
Bladder carcinoma is among the top 10 most frequently diagnosed cancer types in the
world. As a phytochemical active metabolic, thymoquinone (TQ) is extracted from seeds of …